Medium materiality6/10
Janux Therapeutics upgraded to Outperform by Wolfe Research
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wolfe Research upgraded JANX to Outperform; target $23; current price around $17.39; price up 6.96 since signal.
- Wolfe upgrades JANX to Outperform; target $23; price $17.39 (+6.96).
Key facts
- 01
Target: $23
- 02
Posted price: $17.39
- 03
Analyst firm: Wolfe Research
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.